Johnson, Douglas S.
Pfizer (United States)
3 papers on CoChatORCID 0000-0003-2703-6495
Most cited papers
- Verified
Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain
Ahn, K., Johnson, D. S., Mileni, M., Beidler, D., Long, J. Z., McKinney, M. K., Weerapana, E., Sadagopan, N., Liimatta, M., Smith, S. E., et al. (2009) · Chemistry & Biology
Cannabis and Cannabinoid ResearchEicosanoids and Hypertension Pharmacology
Cited by 439
- Verified
Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry
Click Chemistry and ApplicationsEnzyme function and inhibition
Cited by 387
- Verified
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease
Hur, J.-Y., Frost, G. R., Wu, X., Crump, C., Pan, S. J., Wong, E., Barros, M., Li, T., Nie, P., Zhai, Y., et al. (2020) · Nature
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 382
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free